Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1956 1
1958 1
1959 3
1962 3
1963 1
1965 1
1968 1
1971 1
1973 2
1974 1
1976 1
1978 1
1979 4
1981 1
1984 3
1985 8
1986 9
1987 4
1989 13
1990 11
1991 11
1992 11
1993 15
1994 12
1995 11
1996 12
1997 14
1998 30
1999 20
2000 26
2001 31
2002 22
2003 32
2004 28
2005 39
2006 30
2007 38
2008 71
2009 75
2010 66
2011 72
2012 63
2013 68
2014 65
2015 72
2016 95
2017 99
2018 99
2019 93
2020 160
2021 161
2022 78
Text availability
Article attribute
Article type
Publication date

Search Results

1,616 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab in Membranous Nephropathy.
Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, van den Hoogen MWF, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Mayer G, Maas R, Muto M, Moiseev S, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Schönermarck U, Segelmark M, Smith L, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A; RITERM study group. Gauckler P, et al. Among authors: griffin s. Kidney Int Rep. 2021 Jan 13;6(4):881-893. doi: 10.1016/j.ekir.2020.12.035. eCollection 2021 Apr. Kidney Int Rep. 2021. PMID: 33912740 Free PMC article. Review.
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G, Moiseev S, Muto M, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Segelmark M, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A; RITERM study group. Gauckler P, et al. Among authors: griffin s. Autoimmun Rev. 2020 Nov;19(11):102671. doi: 10.1016/j.autrev.2020.102671. Epub 2020 Sep 15. Autoimmun Rev. 2020. PMID: 32942039 Free article. Review.
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases.
Vazquez ML, Kaila N, Strohbach JW, Trzupek JD, Brown MF, Flanagan ME, Mitton-Fry MJ, Johnson TA, TenBrink RE, Arnold EP, Basak A, Heasley SE, Kwon S, Langille J, Parikh MD, Griffin SH, Casavant JM, Duclos BA, Fenwick AE, Harris TM, Han S, Caspers N, Dowty ME, Yang X, Banker ME, Hegen M, Symanowicz PT, Li L, Wang L, Lin TH, Jussif J, Clark JD, Telliez JB, Robinson RP, Unwalla R. Vazquez ML, et al. Among authors: griffin sh. J Med Chem. 2018 Feb 8;61(3):1130-1152. doi: 10.1021/acs.jmedchem.7b01598. Epub 2018 Jan 23. J Med Chem. 2018. PMID: 29298069
Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis.
Gurdasani D, Bhatt S, Costello A, Denaxas S, Flaxman S, Greenhalgh T, Griffin S, Hyde Z, Katzourakis A, McKee M, Michie S, Ratmann O, Reicher S, Scally G, Tomlinson C, Yates C, Ziauddeen H, Pagel C. Gurdasani D, et al. Among authors: griffin s. J R Soc Med. 2021 Nov;114(11):513-524. doi: 10.1177/01410768211052589. Epub 2021 Nov 1. J R Soc Med. 2021. PMID: 34723680 Free PMC article.
Distributional Cost-Effectiveness Analysis Comes of Age.
Cookson R, Griffin S, Norheim OF, Culyer AJ, Chalkidou K. Cookson R, et al. Among authors: griffin s. Value Health. 2021 Jan;24(1):118-120. doi: 10.1016/j.jval.2020.10.001. Epub 2020 Nov 7. Value Health. 2021. PMID: 33431145 Free PMC article. No abstract available.
1,616 results